Fludarabine combination regimen severely affected peripheral blood stem cell mobilization

Acta Haematologica

Volumn 111, Issue 4, 2004, Pages 228-229

  Laszlo, Daniele ^a   Galieni, Piero ^b   Raspadori, Donatella ^c   Tozzi, Monica ^c   Lauria, Francesco ^c   Martinelli, Giovanni ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b San Benedetto del Tronto Hospital   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; FLUDARABINE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOGRAFT; B CELL LEUKEMIA; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SIDE EFFECT; STEM CELL MOBILIZATION; THROMBOCYTE COUNT;

ADULT; AGED; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG EVALUATION; GRAFT SURVIVAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; KINETICS; LEUKEMIA, MYELOID; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; VIDARABINE;

EID: 2642539880     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077572     Document Type: Article

References (8)

1. Johnson S, Smith AG, Loffler H, Osby E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W: Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. Lancet 1996;347:1432-1438.
2. Zinzani P, Lauria F, Rondelli D, Benfenati D, Raspadori D, Bocchia M, Bendandi M, Gozzetti A, Zaja F, Fanin R, Baccarani M, Tura S: Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma. Ann Oncol 1993;4:575-578.
3. Ketterer N, Salles G, Moullet I, Dumontet C, ElJaafari-Corbin A, Tremisi P, Thieblemont C, Durand B, Neidhardt-Berard EM, Samaha H, Rigal D, Coiffier B: Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 1998;103:235-242.
4. Laszlo D, Galieni P, Raspadori D, Scalia G, Bigazzi C, Bocchia M, Bucalossi A, Marotta G, Tozzi M, Lauria F: Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patients. Leuk Lymphoma 2000;37:157-161.
5. Visani G, Lemoli RM, Tosi P, Martinelli G, Testoni N, Ricci P, Piccaluga PP, Pastano R, Leopardi G, Dizdari A, Motta MR, Rizzi S, Tura S: Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients. Br J Haematol 1999;105:775-779.
6. Tournilhac O, Cazin B, Lepretre S, Divine M, Maloum K, Delmer A, Grosbois B, Feugier P, Maloisel F, Villard F, Villemagne B, Bastit D, Belhadj K, Azar N, Michallet M, Manhes G, Travade P: Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. Blood First Edition Paper, prepublished online September 11, 2003.
7. Sala R, Mauro FR, Bellucci R, De Propris MS, Cordone I, Lisci A, Foa R, de Fabritiis P: Evaluation of marrow and blood haematopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy. Eur J Haematol 1998;61:14-20.
8. Michallet M, Thiebaut A, Dreger P, Remes K, Milpied N, Santini G, Hamon M, Bjorkstrand B, Kimby E, Belhabri A, Tanguy ML, Apperley JF: Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): A report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP). Br J Haematol 2000;108:595-601.